XML 95 R77.htm IDEA: XBRL DOCUMENT v3.25.1
Noncontrolling Interests - Schedule of Changes in Noncontrolling Interests and Redeemable Noncontrolling Interest (Details) - USD ($)
$ in Millions
12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]      
Beginning balance $ (1,599) $ (1,490) $ (1,792)
Net income attributable to noncontrolling interests 186 158 162
Payments to noncontrolling interests (178) (152) (150)
Formation of SCRI Oncology     247
Derecognition of noncontrolling interests in McKesson Europe     (382)
Ending balance (1,694) (1,599) (1,490)
Noncontrolling Interests      
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]      
Beginning balance 372 367 480
Net income attributable to noncontrolling interests 186 158 162
Other comprehensive income     44
Payments to noncontrolling interests (178) (152) (150)
Reclassification of recurring compensation to other accrued liabilities     (5)
Formation of SCRI Oncology     225
Derecognition of noncontrolling interests in McKesson Europe     (382)
Other   (1) (7)
Ending balance $ 380 $ 372 $ 367